/MOTS
MOTS Stock - Motus GI Holdings, Inc.
Healthcare|Medical - DevicesOTC
$0.00+0.00%
+$0.00 (+0.00%) • Dec 19
37
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.8
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.0
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $0.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for MOTS
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.00 – $0.00
TARGET (TP)$0.00
STOP LOSS$0.00
RISK/REWARD1:-1.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta3.56
52W High$0.01
52W Low$0.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | $319,000 | $592,000 | $391,000 | $98,000 | $107,000 |
| Gross Profit | $-250,000 | $-204,000 | $-233,000 | $-398,000 | $-29,000 |
| Gross Margin | -78.4% | -34.5% | -59.6% | -406.1% | -27.1% |
| Operating Income | $-11,907,000 | $-17,851,000 | $-17,924,000 | $-19,047,000 | $-23,436,000 |
| Net Income | $-12,867,000 | $-18,597,000 | $-19,033,000 | $-19,257,000 | $-23,086,000 |
| Net Margin | -4033.5% | -3141.4% | -4867.8% | -19650.0% | -21575.7% |
| EPS | $-15.89 | $-86.15 | $-161.07 | $-179.86 | $-269.69 |
Company Overview
Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
0%
Hold / Neutral
1
100%
Sell / Underperform
0%
Analyst Consensus🔴 Bearish
0 Bullish1 Neutral/Bearish
Price Targets
No price targets available
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| January 25th 2023 | Ladenburg Thalmann | Downgrade | Neutral | - |
Earnings History & Surprises
MOTSBeat Rate
73%
Last 15 quarters
Avg Surprise
+19.5%
EPS vs Estimate
Beats / Misses
11/1
3 met exactly
Latest EPS
$-0.88
Q2 2024
EPS Surprise History
Q3 22
+11.0%
$-27.89vs$-31.33
Q4 22
+9.6%
$-25.34vs$-28.04
Q1 23
+36.8%
$-11.84vs$-18.74
Q2 23
+38.6%
$-9.75vs$-15.89
Q3 23
+44.6%
$-5.40vs$-9.75
Q4 23
+40.6%
$-4.28vs$-7.20
Q1 24
+1.4%
$-4.13vs$-4.19
Q2 24
+83.9%
$-0.88vs$-5.48
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2025 | Jul 29, 2025 | — | — | — | — |
Q2 2025 | May 12, 2025 | — | — | — | — |
Q1 2025 | Feb 19, 2025 | — | — | — | — |
Q4 2024 | Nov 14, 2024 | — | — | — | — |
Q3 2024 | Aug 26, 2024 | — | — | — | — |
Q2 2024 | May 14, 2024 | $-5.48 | $-0.88 | +83.9% | ✓ BEAT |
Q1 2024 | Mar 18, 2024 | $-4.19 | $-4.13 | +1.4% | ✓ BEAT |
Q4 2023 | Nov 13, 2023 | $-7.20 | $-4.28 | +40.6% | ✓ BEAT |
Q3 2023 | Aug 14, 2023 | $-9.75 | $-5.40 | +44.6% | ✓ BEAT |
Q2 2023 | May 10, 2023 | $-15.89 | $-9.75 | +38.6% | ✓ BEAT |
Q1 2023 | Mar 31, 2023 | $-18.74 | $-11.84 | +36.8% | ✓ BEAT |
Q4 2022 | Nov 14, 2022 | $-28.04 | $-25.34 | +9.6% | ✓ BEAT |
Q3 2022 | Aug 11, 2022 | $-31.33 | $-27.89 | +11.0% | ✓ BEAT |
Q2 2022 | May 12, 2022 | $-32.98 | $-26.99 | +18.2% | ✓ BEAT |
Q1 2022 | Mar 29, 2022 | $-29.99 | $-29.99 | 0.0% | = MET |
Q4 2021 | Nov 12, 2021 | $-32.98 | $-29.99 | +9.1% | ✓ BEAT |
Q3 2021 | Aug 12, 2021 | $-32.98 | $-29.99 | +9.1% | ✓ BEAT |
Q2 2021 | May 13, 2021 | $-29.99 | $-32.98 | -10.0% | ✗ MISS |
Q1 2021 | Mar 16, 2021 | $-35.98 | $-35.98 | 0.0% | = MET |
Q4 2020 | Nov 12, 2020 | $-38.98 | $-38.98 | 0.0% | = MET |
Latest News
Loading news...
Frequently Asked Questions about MOTS
What is MOTS's current stock price?
Motus GI Holdings, Inc. (MOTS) is currently trading at $0.00 per share. The stock has moved +0.00% today.
What is the analyst price target for MOTS?
No analyst price targets are currently available for this stock.
What sector is Motus GI Holdings, Inc. in?
Motus GI Holdings, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the OTC exchange.
What is MOTS's market cap?
Motus GI Holdings, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.
Does MOTS pay dividends?
No, Motus GI Holdings, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorATRX
Adhera Therapeutics, Inc.
$0.00
Mkt Cap: $0.0B
BIIO
Bionovate Technologies Corp
$0.00
Mkt Cap: $0.0B
CNNXF
CannAmerica Brands Corp.
$0.00
Mkt Cap: $0.0B
GBIM
GlobeImmune, Inc.
$0.00
Mkt Cap: $0.0B
HRAL
Hear AtLast Holdings, Inc.
$0.00
Mkt Cap: $0.0B
IMRSQ
IMRIS Inc.
$0.00
Mkt Cap: $0.0B
MICRD
Micron Solutions, Inc.
$0.00
Mkt Cap: $0.0B
ONCSQ
OncoSec Medical Incorporated
$0.00
Mkt Cap: $0.0B
ROSGQ
Rosetta Genomics Ltd.
$0.00
Mkt Cap: $0.0B
STBV
Strategic Global Investments, Inc.
$0.00
Mkt Cap: $0.0B
Explore stocks similar to MOTS for comparison